BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35682748)

  • 1. Effects of Individual Amino Acids on PPARα Transactivation, mTORC1 Activation, ApoA-I Transcription and pro-ApoA-I Secretion.
    Tayyeb JZ; Popeijus HE; van de Sanden J; Zwaan W; Mensink RP; Plat J
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of short-chain fatty acids on the transcription and secretion of apolipoprotein A-I in human hepatocytes in vitro.
    Tayyeb JZ; Popeijus HE; Mensink RP; Konings MCJM; Mulders KHR; Plat J
    J Cell Biochem; 2019 Oct; 120(10):17219-17227. PubMed ID: 31106471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amoxicillin Modulates ApoA-I Transcription and Secretion, Predominantly via PPARα Transactivation Inhibition.
    Tayyeb JZ; Popeijus HE; Mensink RP; Konings MCJM; Mulders KHR; Plat J
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31783518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-Chain Fatty Acids (Except Hexanoic Acid) Lower NF-kB Transactivation, Which Rescues Inflammation-Induced Decreased Apolipoprotein A-I Transcription in HepG2 Cells.
    Tayyeb JZ; Popeijus HE; Mensink RP; Konings MCJM; Mokhtar FBA; Plat J
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty acid chain length and saturation influences PPARα transcriptional activation and repression in HepG2 cells.
    Popeijus HE; van Otterdijk SD; van der Krieken SE; Konings M; Serbonij K; Plat J; Mensink RP
    Mol Nutr Food Res; 2014 Dec; 58(12):2342-9. PubMed ID: 25255786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large-Scale Screening of Natural Products Transactivating Peroxisome Proliferator-Activated Receptor α Identifies 9S-Hydroxy-10E,12Z,15Z-Octadecatrienoic Acid and Cymarin as Potential Compounds Capable of Increasing Apolipoprotein A-I Transcription in Human Liver Cells.
    van der Krieken SE; Popeijus HE; Bendik I; Böhlendorf B; Konings MCJM; Tayyeb J; Mensink RP; Plat J
    Lipids; 2018 Nov; 53(11-12):1021-1030. PubMed ID: 30706477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Link Between ER-Stress, PPAR-Alpha Activation, and BET Inhibition in Relation to Apolipoprotein A-I Transcription in HepG2 Cells.
    van der Krieken SE; Popeijus HE; Mensink RP; Plat J
    J Cell Biochem; 2017 Aug; 118(8):2161-2167. PubMed ID: 28012209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of beta-3 adrenoceptor stimulation on the levels of ApoA-I, PPARα, and PPARγ in apolipoprotein E-deficient mice.
    Shi ST; Li YF; Guo YQ; Wang ZH
    J Cardiovasc Pharmacol; 2014 Nov; 64(5):407-11. PubMed ID: 24979391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of niacin and chromium on the expression of ATP-binding cassette transporter A1 and apolipoprotein A-1 genes in HepG2 cells.
    Siripurkpong P; Na-Bangchang K
    J Nutr Biochem; 2009 Apr; 20(4):261-8. PubMed ID: 18602814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NFkappaB regulates plasma apolipoprotein A-I and high density lipoprotein cholesterol through inhibition of peroxisome proliferator-activated receptor alpha.
    Morishima A; Ohkubo N; Maeda N; Miki T; Mitsuda N
    J Biol Chem; 2003 Oct; 278(40):38188-93. PubMed ID: 12882972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes.
    Han CY; Chiba T; Campbell JS; Fausto N; Chaisson M; Orasanu G; Plutzky J; Chait A
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1806-13. PubMed ID: 16709944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linoleic acid-enriched phospholipids act through peroxisome proliferator-activated receptors alpha to stimulate hepatic apolipoprotein A-I secretion.
    Pandey NR; Renwick J; Misquith A; Sokoll K; Sparks DL
    Biochemistry; 2008 Feb; 47(6):1579-87. PubMed ID: 18189424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the nuclear receptors HNF4 alpha, PPAR alpha, and LXRs in the TNF alpha-mediated inhibition of human apolipoprotein A-I gene expression in HepG2 cells.
    Mogilenko DA; Dizhe EB; Shavva VS; Lapikov IA; Orlov SV; Perevozchikov AP
    Biochemistry; 2009 Dec; 48(50):11950-60. PubMed ID: 19883121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C/EBP-β Is Differentially Affected by PPARα Agonists Fenofibric Acid and GW7647, But Does Not Change Apolipoprotein A-I Production During ER-Stress and Inflammation.
    van der Krieken SE; Popeijus HE; Konings M; Dullens SP; Mensink RP; Plat J
    J Cell Biochem; 2017 Apr; 118(4):754-763. PubMed ID: 27618583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oil.
    Dallongeville J; Baugé E; Tailleux A; Peters JM; Gonzalez FJ; Fruchart JC; Staels B
    J Biol Chem; 2001 Feb; 276(7):4634-9. PubMed ID: 11050100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTORC1-dependent protein synthesis and autophagy uncouple in the regulation of Apolipoprotein A-I expression.
    Georgila K; Gounis M; Havaki S; Gorgoulis VG; Eliopoulos AG
    Metabolism; 2020 Apr; 105():154186. PubMed ID: 32084429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel selective peroxisome proliferator-activated receptor alpha agonist, 2-methyl-2-(4-{3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl}phenoxy)propanoic acid (LY518674), that produces marked changes in serum lipids and apolipoprotein A-1 expression.
    Singh JP; Kauffman R; Bensch W; Wang G; McClelland P; Bean J; Montrose C; Mantlo N; Wagle A
    Mol Pharmacol; 2005 Sep; 68(3):763-8. PubMed ID: 15933217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates.
    Vu-Dac N; Chopin-Delannoy S; Gervois P; Bonnelye E; Martin G; Fruchart JC; Laudet V; Staels B
    J Biol Chem; 1998 Oct; 273(40):25713-20. PubMed ID: 9748239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly sensitive upregulation of apolipoprotein A-IV by peroxisome proliferator-activated receptor alpha (PPARalpha) agonist in human hepatoma cells.
    Nagasawa M; Akasaka Y; Ide T; Hara T; Kobayashi N; Utsumi M; Murakami K
    Biochem Pharmacol; 2007 Dec; 74(12):1738-46. PubMed ID: 17904533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha.
    Ng VY; Huang Y; Reddy LM; Falck JR; Lin ET; Kroetz DL
    Drug Metab Dispos; 2007 Jul; 35(7):1126-34. PubMed ID: 17431031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.